COVID-19 Pandemic Increases Demand for Vaccine Delivery Devices

---

Researched by Industrial Info Resources (Sugar Land, Texas)--As companies continue to develop vaccines to combat the pandemic, there is a growing need for needles, syringes and other vaccine delivery devices. Companies like Apiject and Becton and Dickenson (BD) are investing millions to produce the ancillary equipment needed for the vaccines. Apiject is investing nearly a billion dollars for a new facility in Durham, North Carolina. This facility will produce single-dose, pre-filled auto-injectors which will be used for the COVID-19 vaccine. BD is investing millions at its existing facilities in Columbus, Nebraska, (East and West sites) to increase the manufacturing of needles and syringes.

There are more than 210 projects totaling $1.85 billion in North America for the surgical and medical instruments manufacturing sector, according to Industrial Info's Global Market Intelligence Platform. Click here for a list.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at https://www.industrialinfo.com.